Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September

(Reuters) – Inovio Pharmaceuticals Inc expects its experimental COVID-19 vaccine to enter mid-to-late stage study in September and secure U.S. …

Source: Inovio to begin mid-to-late stage study of COVID-19 vaccine candidate in September